⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanidine SCHEMBL27561077 | 0.88 | PTGS1 (0.33) | — | |
| SCHEMBL17183009 | 0.83 | — | — | |
| SCHEMBL28505751 | 0.81 | FNTA (0.39) | — | |
| SCHEMBL562188 | 0.81 | CA2 (0.44) | — | |
| SCHEMBL17183004 | 0.79 | FNTA (0.46) | — | |
| SCHEMBL17183010 | 0.79 | FNTA (0.46) | — | |
| SCHEMBL3655506 | 0.79 | FNTA (0.46) | — | |
| Ammonia Solution, Strong SCHEMBL1552139 | 0.78 | CA2 (0.41) | — | |
| SCHEMBL17456450 | 0.78 | CA2 (0.41) | — | |
| SCHEMBL3640927 | 0.75 | CA2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119060256-A | Preparation method of salt-tolerant strong cation exchange chromatography medium | 北京石油化工学院 | 2024-12-03 | — | — | CN | claimed |
| CN-108070009-B | Method for preparing DNA coding compound library and initial fragment compound and prepared DNA coding compound | 上海药明康德新药开发有限公司 | 2021-04-13 | — | — | CN | claimed |
| US-7910568-B2 | Inflammatory bowel disease, irritable bowel syndrome, Crohn's disease, ulcerative colitis, gastrointestinal disorders; prevention/treatment of colon cancer; releases hydrogen sulfide | ANTIBE THERAPEUTICS INC. (CA) | 2011-03-22 | — | — | US | claimed |
| US-20090233886-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2009-09-17 | — | — | US | claimed |
| US-20080207564-A1 | Derivaitves of 4-Or 5-Aminosalicylic Acid | ANTIBE THERAPEUTICS INC. (CA) | 2008-08-28 | — | — | US | claimed |
| EP-1883645-A4 | DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC (US) | 2008-06-25 | — | — | EP | claimed |
| EP-1883645-A1 | DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID | Antibe Therapeutics Inc. (US) | 2008-02-06 | — | — | EP | claimed |
| US-20070197479-A1 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2007-08-23 | — | — | US | claimed |
| WO-2006125295-A1 | DERIVATIVES OF 4-OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2006-11-30 | — | — | WO | claimed |
| US-20060270635-A1 | Derivatives of 4- or 5-aminosalicylic acid | ANTIBE THERAPEUTICS INC. (CA) | 2006-11-30 | — | — | US | claimed |
| WO-2006125293-A1 | DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID | ANTIBE THERAPEUTICS INC. (CA) | 2006-11-30 | — | — | WO | claimed |
| US-4051314-A | FROM FUNGUS OF CLASS BASIDIOMYCETES, ANTICANCER AGENTS | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-09-27 | — | — | US | claimed |
| CN-119060256-A | Preparation method of salt-tolerant strong cation exchange chromatography medium | 北京石油化工学院 | 2024-12-03 | — | — | CN | disclosed |
| CN-111417735-B | Copper fine particle sintered body | DIC株式会社 | 2022-10-04 | — | — | CN | disclosed |
| CN-108070009-B | Method for preparing DNA coding compound library and initial fragment compound and prepared DNA coding compound | 上海药明康德新药开发有限公司 | 2021-04-13 | — | — | CN | disclosed |
| EP-2762485-B1 | METHOD FOR PRODUCING POLYPEPTIDE FRAGMENT WITH HIGH EFFICIENCY, WHICH IS SUITABLE FOR NCL METHOD | GLYTECH INC (JP) | 2018-08-01 | — | — | EP | disclosed |
| EP-0295955-A2 | Lectins and antiretroviral drugs containing the lectins as active ingredients | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| EP-0295962-A2 | Protein-polysaccharide for treating retroviral infections | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| EP-0295956-A2 | Use of a protein-bound polysaccharide for making a drug for treating AIDS. | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-12-21 | — | — | EP | disclosed |
| US-4051314-A | FROM FUNGUS OF CLASS BASIDIOMYCETES, ANTICANCER AGENTS | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1977-09-27 | — | — | US | disclosed |